Loading...
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
Future treatments of multiple sclerosis (MS), a chronic autoimmune neurodegenerative disease of the central nervous system (CNS), aim for simultaneous early targeting of peripheral immune function and neuroinflammation. Sphingosine-1-phosphate (S1P) receptor modulators are among the most promising d...
Saved in:
| Published in: | Cells |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7291065/ https://ncbi.nlm.nih.gov/pubmed/32455907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9051290 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|